top of page
$34.49
chg
-0.10 (-0.29%)
quotes and stock data may be delayed 15 minutes
My Notes
Only BPIQ Pro members can create company notes. Learn more here.
52 wk low
0
52 wk hi
34.49
Cash
$358.4M
Burn Rate (Qtr)
-$69.2M
Mkt Cap
$2.3b
Avg Volume
0
*cash/burn updated:
Q1' 20
Drug Pipeline
Click the button to see the updated pipeline
No drug found
We don't have any drug data for this company yet
Drug | Disease (links)
Stage (next event)
Catalyst Date
Loading Catalysts...
search in progress
Pipeline powered by
AIMT
Company Profile
Aimmune Therapeutics is a biopharmaceutical company developing and bringing new treatments to people with potentially life-threatening food allergies.
Recent Posts
See what the community is saying - click to see full post.
bottom of page